For: | Yamamoto Y, Ikoma H, Morimura R, Konishi H, Murayama Y, Komatsu S, Shiozaki A, Kuriu Y, Kubota T, Nakanishi M, Ichikawa D, Fujiwara H, Okamoto K, Sakakura C, Ochiai T, Otsuji E. Optimal duration of the early and late recurrence of hepatocellular carcinoma after hepatectomy. World J Gastroenterol 2015; 21(4): 1207-1215 [PMID: 25632194 DOI: 10.3748/wjg.v21.i4.1207] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i4/1207.htm |
Number | Citing Articles |
1 |
Haohan Liu, Yongcong Yan, Ruibing Chen, Mengdi Zhu, Jianhong Lin, Chuanchao He, Bingchao Shi, Kai Wen, Kai Mao, Zhiyu Xiao. Integrated nomogram based on five stage-related genes and TNM stage to predict 1-year recurrence in hepatocellular carcinoma. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01216-9
|
2 |
Jae H Yoon, Young J Goo, Chae-Jun Lim, Sung K Choi, Sung B Cho, Sang S Shin, Chung H Jun. Features of extrahepatic metastasis after radiofrequency ablation for hepatocellular carcinoma. World Journal of Gastroenterology 2020; 26(32): 4833-4845 doi: 10.3748/wjg.v26.i32.4833
|
3 |
Dongyao Wang, Xiaohu Zheng, Binqing Fu, Zhigang Nian, Yeben Qian, Rui Sun, Zhigang Tian, Haiming Wei. Hepatectomy promotes recurrence of liver cancer by enhancing IL-11-STAT3 signaling. eBioMedicine 2019; 46: 119 doi: 10.1016/j.ebiom.2019.07.058
|
4 |
Pinxiong Li, Lei Wu, Zhenhui Li, Jiao Li, Weitao Ye, Zhenwei Shi, Zeyan Xu, Chao Zhu, Huifen Ye, Zaiyi Liu, Changhong Liang. Spleen Radiomics Signature: A Potential Biomarker for Prediction of Early and Late Recurrences of Hepatocellular Carcinoma After Resection. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.716849
|
5 |
Baek Gyu Jun, Woong Cheul Lee, Jae Young Jang, Soung Won Jeong, Young Chang, Sae Hwan Lee, Young don Kim, Sang Gyune Kim, Gab Jin Cheon, Young Seok Kim, Hong Soo Kim, So Young Jin, Matias A Avila. Relation of fibroblast growth factor receptor 2 expression to hepatocellular carcinoma recurrence after liver resection. PLOS ONE 2020; 15(1): e0227440 doi: 10.1371/journal.pone.0227440
|
6 |
Yufeng Lv, Wenhao Wei, Zhong Huang, Zhichao Chen, Yuan Fang, Lili Pan, Xueqiong Han, Zihai Xu. Long non‐coding RNA expression profile can predict early recurrence in hepatocellular carcinoma after curative resection. Hepatology Research 2018; 48(13): 1140 doi: 10.1111/hepr.13220
|
7 |
Kelvin K. Ng, Tan-To Cheung, Herbert H. Pang, Tiffany C. Wong, Jeff W. Dai, Ka-Wing Ma, Wong-Hoi She, C.Nicholas Kotewall, Chung-Mau Lo. A simplified prediction model for early intrahepatic recurrence after hepatectomy for patients with unilobar hepatocellular carcinoma without macroscopic vascular invasion: An implication for adjuvant therapy and postoperative surveillance. Surgical Oncology 2019; 30: 6 doi: 10.1016/j.suronc.2019.05.017
|
8 |
Ye Lu, Huanhuan Wang, Chenxia Li, Ferdos Faghihkhorasani, Cheng Guo, Xin Zheng, Tao Song, Qingguang Liu, Shaoshan Han. Preoperative and postoperative MRI-based models versus clinical staging systems for predicting early recurrence in hepatocellular carcinoma. European Journal of Surgical Oncology 2024; 50(9): 108476 doi: 10.1016/j.ejso.2024.108476
|
9 |
Chuan Li, Jun-Yi Shen, Xiao-Yun Zhang, Wei Peng, Tian-Fu Wen, Jia-Yin Yang, Lu-Nan Yan. Predictors of Futile Liver Resection for Patients with Barcelona Clinic Liver Cancer Stage B/C Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery 2018; 22(3): 496 doi: 10.1007/s11605-017-3632-6
|
10 |
Cyprien Toubert, Boris Guiu, Bader Al Taweel, Eric Assenat, Fabrizio Panaro, François-Regis Souche, Jose Ursic-Bedoya, Francis Navarro, Astrid Herrero. Prolonged Survival after Recurrence in HCC Resected Patients Using Repeated Curative Therapies: Never Give Up!. Cancers 2022; 15(1): 232 doi: 10.3390/cancers15010232
|
11 |
Xingzhi Li, Zhihong Tang, Qingqing Pang, Xiaobo Wang, Tao Bai, Jie Chen, Meng Wei, Tao Wei, Lequn Li, Feixiang Wu. The Role of Timing of Progression and Early Salvage Surgery in Unresectable Hepatocellular Carcinoma Treated with TACE Plus TKIs and PD‑1 Inhibitors. Journal of Hepatocellular Carcinoma 2024; : 1641 doi: 10.2147/JHC.S481816
|
12 |
Xuanzhi Yan, Yicheng Li, Wanying Qin, Jiayi Liao, Jiaxing Fan, Yujin Xie, Zewen Wang, Siming Li, Weijia Liao. Radiomics model based on contrast-enhanced computed tomography imaging for early recurrence monitoring after radical resection of AFP-negative hepatocellular carcinoma. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12436-x
|
13 |
Changcheng Tao, Nan Hu, Yue Liu, Hongwei Wang, Zhihao Wang, Kai Zhang, Liming Wang, Bo Chen, Fan Wu, Weiqi Rong, Jianxiong Wu. Long-term outcome of adjuvant radiotherapy upon postoperative relapse of centrally located hepatocellular carcinoma: a real-world study. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-59180-7
|
14 |
Han Ah Lee, Young-Sun Lee, Beom Kyung Kim, Young Kul Jung, Seung Up Kim, Jun Yong Park, Ji Hoon Kim, Hyunggin An, Do Young Kim, Hyung Joon Yim, Sang Hoon Ahn, Jong Eun Yeon, Kwan Soo Byun, Kwang-Hyub Han, Soon Ho Um, Yeon Seok Seo. Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma. Gut and Liver 2021; 15(3): 420 doi: 10.5009/gnl20101
|
15 |
Jian Zheng, Jayasree Chakraborty, William C. Chapman, Scott Gerst, Mithat Gonen, Linda M. Pak, William R. Jarnagin, Ronald P. DeMatteo, Richard K.G. Do, Amber L. Simpson, Peter J. Allen, Vinod P. Balachandran, Michael I. D'Angelica, Peter T Kingham, Neeta Vachharajani. Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma Using Quantitative Image Analysis. Journal of the American College of Surgeons 2017; 225(6): 778 doi: 10.1016/j.jamcollsurg.2017.09.003
|
16 |
Katsunori Sakamoto, Kohei Ogawa, Taiji Tohyama, Yoshitomo Ueno, Kei Tamura, Hitoshi Inoue, Taro Nakamura, Jota Watanabe, Akihiro Takai, Yasutsugu Takada. Serosal invasion is a strong prognostic factor for hepatocellular carcinoma after hepatectomy. Hepatology Research 2019; 49(4): 419 doi: 10.1111/hepr.13285
|
17 |
Changying Shi, Qian Zhao, Boyi Liao, Zhitao Dong, Can Wang, Jiamei Yang, Weifeng Shen. Anatomic resection and wide resection margin play an important role in hepatectomy for hepatocellular carcinoma with peritumoural micrometastasis. ANZ Journal of Surgery 2019; 89(11) doi: 10.1111/ans.15396
|
18 |
Shoufei Jiao, Guanqun Li, Dongxin Zhang, Yingchen Xu, Jie Liu, Guangming Li. Anatomic versus non-anatomic resection for hepatocellular carcinoma, do we have an answer? A meta-analysis. International Journal of Surgery 2020; 80: 243 doi: 10.1016/j.ijsu.2020.05.008
|
19 |
Sungwon Kim, Jaeseung Shin, Do-Young Kim, Gi Hong Choi, Myeong-Jin Kim, Jin-Young Choi. Radiomics on Gadoxetic Acid–Enhanced Magnetic Resonance Imaging for Prediction of Postoperative Early and Late Recurrence of Single Hepatocellular Carcinoma. Clinical Cancer Research 2019; 25(13): 3847 doi: 10.1158/1078-0432.CCR-18-2861
|
20 |
Zhongdong Xie, Qingwei Zhang, Xiaojie Wang, Yongchun Chen, Yu Deng, Hanbin Lin, Jiashu Wu, Xinming Huang, Zongbin Xu, Pan Chi. Development and validation of a novel radiomics nomogram for prediction of early recurrence in colorectal cancer. European Journal of Surgical Oncology 2023; 49(12): 107118 doi: 10.1016/j.ejso.2023.107118
|
21 |
Zhi-Ming Zhang, Yu-Mei Zhang, Feng Yao, Ping Yi, Shang Huang, Jian-Yong Liu, Bang-De Xiang, Wei-Ping Yuan, Le-Qun Li. Analysis on Postoperative Efficacy of Radical Hepatectomy for Patients with Non-HBV/HCV Hepatocellular Carcinoma. Asian Pacific Journal of Cancer Prevention 2015; 16(8): 3479 doi: 10.7314/APJCP.2015.16.8.3479
|
22 |
Tianyi Wang, Mingkai Li, Zebin Chen, Xi Chen, Haimei Chen, Bin Wu, Xiaoying Wu, Yue Li, Yao Lu, Khan M. Iftekharuddin, Weijie Chen. Tensor based multi-modality fusion for prediction of postoperative early recurrence of single hepatocellular carcinoma. Medical Imaging 2023: Computer-Aided Diagnosis 2023; : 73 doi: 10.1117/12.2653685
|
23 |
Jian Zheng, Deborah Kuk, Mithat Gönen, Vinod P. Balachandran, T. Peter Kingham, Peter J. Allen, Michael I. D’Angelica, William R. Jarnagin, Ronald P. DeMatteo. Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma. Annals of Surgical Oncology 2017; 24(5): 1358 doi: 10.1245/s10434-016-5713-2
|
24 |
Jung Il Lee, Hyun Woong Lee, Seung Up Kim, Sang Hoon Ahn, Kwan Sik Lee. Follow-Up Liver Stiffness Measurements after Liver Resection Influence Oncologic Outcomes of Hepatitis-B-Associated Hepatocellular Carcinoma with Liver Cirrhosis. Cancers 2019; 11(3): 425 doi: 10.3390/cancers11030425
|
25 |
Heng-Yuan Hsu, Ming-Chin Yu, Chao-Wei Lee, Hsin-I Tsai, Chang-Mu Sung, Chun-Wei Chen, Shu-Wei Huang, Cheng-Yu Lin, Wen-Juei Jeng, Wei-Chen Lee, Miin-Fu Chen. RAM score is an effective predictor for early mortality and recurrence after hepatectomy for hepatocellular carcinoma. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3748-9
|
26 |
Mohamed Hassany, Aisha Elsharkawy, Amr Maged, Mai Mehrez, Noha Asem, Ahmed Gomaa, Zeinab Mostafa, Bahaa Abbas, Mohamad Soliman, Gamal Esmat. Hepatitis C virus treatment by direct-acting antivirals in successfully treated hepatocellular carcinoma and possible mutual impact. European Journal of Gastroenterology & Hepatology 2018; 30(8): 876 doi: 10.1097/MEG.0000000000001152
|
27 |
Xinyuan Zhang, Yujing Xin, Yi Yang, Yi Chen, Xiao-jing Cao, Yanan Wang, Qingsheng Fan, Xiang Zhou, Xiao Li. Aspartate aminotransferase-to-platelet ratio index for predicting late recurrence of hepatocellular carcinoma after radiofrequency ablation. International Journal of Hyperthermia 2022; 39(1): 437 doi: 10.1080/02656736.2022.2043457
|
28 |
Masaki Ueno, Shinya Hayami, Manabu Kawai, Seiko Hirono, Ken-ichi Okada, Motoki Miyazawa, Yuji Kitahata, Atsushi Miyamoto, Norihiko Suzaki, Masashi Nakamura, Hiroki Yamaue. Prognostic impact of adjuvant chemolipiodolization and treatment frequency on patients with hepatocellular carcinoma after hepatectomy: Prospective study with historical control group. Surgical Oncology 2021; 36: 99 doi: 10.1016/j.suronc.2020.12.002
|
29 |
Fang Wang, Ming Cheng, Binbin Du, Li-ming Li, Wen-peng Huang, Jian-bo Gao. Use of radiomics containing an effective peritumoral area to predict early recurrence of solitary hepatocellular carcinoma ≤5 cm in diameter. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1032115
|
30 |
Hirotaka Furuke, Tomohiro Arita, Yoshiaki Kuriu, Hiroki Shimizu, Jun Kiuchi, Yusuke Yamamoto, Hirotaka Konishi, Ryo Morimura, Atsushi Shiozaki, Hisashi Ikoma, Takeshi Kubota, Masayoshi Nakanishi, Hitoshi Fujiwara, Kazuma Okamoto, Eigo Otsuji. The survival after recurrence of colorectal cancer: a retrospective study focused on time to recurrence after curative resection. Surgery Today 2022; 52(2): 239 doi: 10.1007/s00595-021-02336-z
|
31 |
Maria Tampaki, George Vasileios Papatheodoridis, Evangelos Cholongitas. Intrahepatic recurrence of hepatocellular carcinoma after resection: an update. Clinical Journal of Gastroenterology 2021; 14(3): 699 doi: 10.1007/s12328-021-01394-7
|
32 |
Yong Yang, Shuqi Mao, Jiongze Fang, Gaoqing Wang, Yuying Shan, Xi Yu, Caide Lu. Macrotrabecular-massive subtype-based nomogram to predict early recurrence of hepatocellular carcinoma after surgery. European Journal of Gastroenterology & Hepatology 2023; 35(4): 505 doi: 10.1097/MEG.0000000000002525
|
33 |
Jihye Kim, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik. Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients. Clinical and Molecular Hepatology 2020; 26(4): 516 doi: 10.3350/cmh.2020.0016
|
34 |
Lan-Qing Yao, Zheng-Liang Chen, Zi-Han Feng, Yong-Kang Diao, Chao Li, Hai-Ying Sun, Jian-Hong Zhong, Ting-Hao Chen, Wei-Min Gu, Ya-Hao Zhou, Wan-Guang Zhang, Hong Wang, Yong-Yi Zeng, Han Wu, Ming-Da Wang, Xin-Fei Xu, Timothy M. Pawlik, Wan Yee Lau, Feng Shen, Tian Yang. Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional Analysis. Annals of Surgical Oncology 2022; 29(7): 4291 doi: 10.1245/s10434-022-11454-y
|
35 |
Zhi‐Jie Ma, Jun‐Xi Xiang, Matthew Weiss, Irinel Popescu, Hugo P. Marques, Luca Aldrighetti, Shishir K. Maithel, Carlo Pulitano, Todd W. Bauer, Feng Shen, George A. Poultsides, Oliver Soubrane, Guillaume Martel, Bas Groot Koerkamp, Endo Itaru, Yi Lyu, Xu‐Feng Zhang, Timothy M. Pawlik. Long‐term survivors after curative‐intent resection for intrahepatic cholangiocarcinoma. Journal of Surgical Oncology 2024; 130(3): 443 doi: 10.1002/jso.27739
|
36 |
Qi Qu, Mengtian Lu, Lei Xu, Jiyun Zhang, Maotong Liu, Jifeng Jiang, Xiance Zhao, Xueqin Zhang, Tao Zhang. A model incorporating histopathology and preoperative gadoxetic acid-enhanced MRI to predict early recurrence of hepatocellular carcinoma without microvascular invasion after curative hepatectomy. The British Journal of Radiology 2023; 96(1144) doi: 10.1259/bjr.20220739
|
37 |
Kai Zhang, Changcheng Tao, Fan Wu, Tana Siqin, Jianxiong Wu, Weiqi Rong. Establishment and Evaluation of a Predictive Model for Early Postoperative Recurrence of Hepatocellular Carcinoma in Patients with Microvascular Invasion. International Journal of General Medicine 2021; : 2259 doi: 10.2147/IJGM.S303896
|
38 |
Shu-Qun Li, Li-Li Su, Ting-Feng Xu, Li-Ying Ren, Dong-Bo Chen, Wan-Ying Qin, Xuan-Zhi Yan, Jia-Xing Fan, Hong-Song Chen, Wei-Jia Liao. Radiomics model based on contrast-enhanced computed tomography to predict early recurrence in patients with hepatocellular carcinoma after radical resection. World Journal of Gastroenterology 2023; 29(26): 4186-4199 doi: 10.3748/wjg.v29.i26.4186
Abstract(480) |
Core Tip(493) |
Full Article(HTML)(1526)
|
Full Article with Cover (PDF)-7238K(79)
|
Full Article (Word)-4822K(28)
|
Audio-104K(2)
|
Peer-Review Report-390K(48)
|
Answering Reviewers-126K(51)
|
Supplementary Material-228K(54)
|
Full Article (PDF)-6972K(132)
|
Full Article (XML)-118K(49)
|
Times Cited (3)
|
Total Visits (6194)
|
Open
|
39 |
Esther Ern-Hwei Chan, Pierce Kah-Hoe Chow. A review of prognostic scores after liver resection in hepatocellular carcinoma: the MSKCC, SLICER and SSCLIP scores. Japanese Journal of Clinical Oncology 2016; doi: 10.1093/jjco/hyw185
|
40 |
Bin-bin Xu, Jun Lu, Zhi-fang Zheng, Jian-wei Xie, Jia-bin Wang, Jian-xian Lin, Qi-yue Chen, Long-long Cao, Mi Lin, Ru-hong Tu, Ze-ning Huang, Ju-li Lin, Chao-hui Zheng, Chang-ming Huang, Ping Li. The predictive value of the preoperative C-reactive protein–albumin ratio for early recurrence and chemotherapy benefit in patients with gastric cancer after radical gastrectomy: using randomized phase III trial data. Gastric Cancer 2019; 22(5): 1016 doi: 10.1007/s10120-019-00936-w
|
41 |
Hao Xing, Wan-Guang Zhang, Matteo Cescon, Lei Liang, Chao Li, Ming-Da Wang, Han Wu, Wan Yee Lau, Ya-Hao Zhou, Wei-Min Gu, Hong Wang, Ting-Hao Chen, Yong-Yi Zeng, Myron Schwartz, Timothy M. Pawlik, Matteo Serenari, Feng Shen, Meng-Chao Wu, Tian Yang. Defining and predicting early recurrence after liver resection of hepatocellular carcinoma: a multi-institutional study. HPB 2020; 22(5): 677 doi: 10.1016/j.hpb.2019.09.006
|
42 |
Xin-Fei Xu, Hao Xing, Jun Han, Zhen-Li Li, Wan-Yee Lau, Ya-Hao Zhou, Wei-Min Gu, Hong Wang, Ting-Hao Chen, Yong-Yi Zeng, Chao Li, Meng-Chao Wu, Feng Shen, Tian Yang. Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma. JAMA Surgery 2019; 154(3): 209 doi: 10.1001/jamasurg.2018.4334
|
43 |
Chun‐Yu Lin, Chih‐Che Lin, Chih‐Chi Wang, Chao‐Long Chen, Tsung‐Hui Hu, Chao‐Hung Hung, Pao‐Yuan Huang, Ming‐Chao Tsai. The ALBI Grade is a Good Predictive Model for Very Late Recurrence in Patients with Hepatocellular Carcinoma Undergoing Primary Resection. World Journal of Surgery 2020; 44(1): 247 doi: 10.1007/s00268-019-05197-3
|
44 |
B. Allignet, P. Merle, A. Rode, J.Y. Mabrut, K. Mohkam, F. Mornex. Transarterial chemoembolization followed by moderately hypofractionated radiotherapy in hepatocellular carcinoma: Long-term results of RTF3 regimen. Cancer/Radiothérapie 2023; 27(4): 296 doi: 10.1016/j.canrad.2023.01.004
|
45 |
Jian-Wei Sun, Dao-Li Liu, Jia-Xian Chen, Li-Zhen Lin, Lv-Ping Zhuang, Xian-Hai Hou. Early and late recurrences in lymph node-negative gastric cancer: a retrospective cohort study. Annals of Saudi Medicine 2021; 41(6): 336 doi: 10.5144/0256-4947.2021.336
|
46 |
Yu Zhu, Lingling Gu, Ting Chen, Guoqun Zheng, Chao Ye, Weidong Jia. Factors influencing early recurrence of hepatocellular carcinoma after curative resection. Journal of International Medical Research 2020; 48(8) doi: 10.1177/0300060520945552
|
47 |
Zhen-Li Li, Wen-Tao Yan, Jin Zhang, Yi-Jun Zhao, Wan Yee Lau, Xian-Hai Mao, Yong-Yi Zeng, Ya-Hao Zhou, Wei-Min Gu, Hong Wang, Ting-Hao Chen, Jun Han, Hao Xing, Han Wu, Chao Li, Ming-Da Wang, Meng-Chao Wu, Feng Shen, Tian Yang. Identification of Actual 10-Year Survival After Hepatectomy of HBV-Related Hepatocellular Carcinoma: a Multicenter Study. Journal of Gastrointestinal Surgery 2019; 23(2): 288 doi: 10.1007/s11605-018-4006-4
|
48 |
Yu Wang, Peng Yang Tan, Yohana Ayupriyanti Handoko, Karthik Sekar, Ming Shi, Chan Xie, Xiao‐Dan Jiang, Qing‐Zhe Dong, Brian Kim Poh Goh, London Lucien Ooi, Zhiliang Gao, Kam Man Hui. NUF2 is a valuable prognostic biomarker to predict early recurrence of hepatocellular carcinoma after surgical resection. International Journal of Cancer 2019; 145(3): 662 doi: 10.1002/ijc.32134
|
49 |
Nanbao Zhong, Guangming Lv, Zhonghua Chen. High Dose-Volume SBRT Following TACE Improves Clinical Outcomes of Patients with Unresectable Hepatocellular Carcinoma. Journal of Cancer Therapy 2016; 7(02): 152 doi: 10.4236/jct.2016.72016
|
50 |
Mi Young Jeon, Hye Soo Kim, Tae Seop Lim, Dai Hoon Han, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Gi Hong Choi, Jin Sub Choi, Kwang-Hyub Han, Seung Up Kim, Gianfranco D. Alpini. Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection. PLOS ONE 2019; 14(4): e0214613 doi: 10.1371/journal.pone.0214613
|
51 |
Riccardo Nevola, Rachele Ruocco, Livio Criscuolo, Angela Villani, Maria Alfano, Domenico Beccia, Simona Imbriani, Ernesto Claar, Domenico Cozzolino, Ferdinando Carlo Sasso, Aldo Marrone, Luigi Elio Adinolfi, Luca Rinaldi. Predictors of early and late hepatocellular carcinoma recurrence. World Journal of Gastroenterology 2023; 29(8): 1243-1260 doi: 10.3748/wjg.v29.i8.1243
|
52 |
Chan Woo Cho, Gyu-Seong Choi, Jong Man Kim, Choon Hyuck David Kwon, Doo Jin Kim, Jae-Won Joh. Clinical usefulness of transarterial chemoembolization response prior to liver transplantation as predictor of optimal timing for living donor liver transplantation. Annals of Surgical Treatment and Research 2018; 95(2): 111 doi: 10.4174/astr.2018.95.2.111
|
53 |
Bong Kyung Bae, Hee Chul Park, Gyu Sang Yoo, Moon Seok Choi, Joo Hyun Oh, Jeong Il Yu. The Significance of Systemic Inflammation Markers in Intrahepatic Recurrence of Early-Stage Hepatocellular Carcinoma after Curative Treatment. Cancers 2022; 14(9): 2081 doi: 10.3390/cancers14092081
|
54 |
Jing Liang, Yi Bai, Fu-Shuang Ha, Ying Luo, Hui-Ting Deng, Ying-Tang Gao. Combining local regional therapy and systemic therapy: Expected changes in the treatment landscape of recurrent hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2023; 15(1): 1-18 doi: 10.4251/wjgo.v15.i1.1
|
55 |
Zhifang Zheng, Xiaojie Wang, Ying Huang, Xingrong Lu, Zhekun Huang, Pan Chi. Defining and predicting early recurrence in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. European Journal of Surgical Oncology 2020; 46(11): 2057 doi: 10.1016/j.ejso.2020.07.019
|
56 |
Xiao-Chun Ni, Yong Yi, Yi-Peng Fu, Xiao-Yan Cai, Gao Liu, Jin-Long Huang, Wei Gan, Jie Xu, Shuang-Jian Qiu. <p>Role of Lipids and Apolipoproteins in Predicting the Prognosis of Hepatocellular Carcinoma After Resection</p>. OncoTargets and Therapy 2020; : 12867 doi: 10.2147/OTT.S279997
|
57 |
Masahiko Kinoshita, Daiju Ueda, Toshimasa Matsumoto, Hiroji Shinkawa, Akira Yamamoto, Masatsugu Shiba, Takuma Okada, Naoki Tani, Shogo Tanaka, Kenjiro Kimura, Go Ohira, Kohei Nishio, Jun Tauchi, Shoji Kubo, Takeaki Ishizawa. Deep Learning Model Based on Contrast-Enhanced Computed Tomography Imaging to Predict Postoperative Early Recurrence after the Curative Resection of a Solitary Hepatocellular Carcinoma. Cancers 2023; 15(7): 2140 doi: 10.3390/cancers15072140
|
58 |
Wanmin Liu, Kairong Song, Wei Zheng, Lei Huo, Sisi Zhang, Xiaowen Xu, Peijun Wang, Ningyang Jia. Hepatobiliary Phase Features of Preoperative Gadobenate-Enhanced MR can Predict Early Recurrence of Hepatocellular Carcinoma in Patients Who Underwent Anatomical Hepatectomy. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.862967
|
59 |
Hua Yang, Jie Wang, Zehuan Li, Yi Yang, Liuxiao Yang, Yong Zhang, Yinghong Shi, Ya Cao, Jian Zhou, Zheng Wang, Qing Chen. Risk Factors and Outcomes of Early Relapse After Curative Resection of Intrahepatic Cholangiocarcinoma. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00854
|
60 |
Young Mi Hong, Mong Cho, Ki Tae Yoon, Chong Woo Chu, Kwang Ho Yang, Yong Mok Park, Je Ho Rhu. Risk factors of early recurrence after curative hepatectomy in hepatocellular carcinoma. Tumor Biology 2017; 39(10): 101042831772086 doi: 10.1177/1010428317720863
|
61 |
Changcheng Tao, Fan Wu, Hongwei Wang, Liming Wang, Yue Liu, Anke Wu, Linlin Zheng, Yaru Wang, Bo Chen, Weiqi Rong, Jianxiong Wu. Clinical Benefits of Neoadjuvant Radiotherapy on the Postoperative Recurrence of Centrally Located Hepatocellular Carcinoma: A Real-World Evidence Based on Phase II Clinical Trial. Journal of Hepatocellular Carcinoma 2023; : 753 doi: 10.2147/JHC.S403287
|
62 |
Hajime Matsushima, Yuko Takami, Tomoki Ryu, Munehiro Yoshitomi, Masaki Tateishi, Yoshiyuki Wada, Hideki Saitsu. Prognosis of Hepatocellular Carcinoma Patients Who Achieved Long-Term Recurrence-Free Survival After Curative Therapy: Impact of the ALBI Grade. Journal of Gastrointestinal Surgery 2018; 22(7): 1230 doi: 10.1007/s11605-018-3745-6
|
63 |
Haibin Tu, Siyi Feng, Lihong Chen, Yujie Huang, Juzhen Zhang, Xiaoxiong Wu. Contrast enhanced ultrasound combined with serology predicts hepatocellular carcinoma recurrence: a retrospective observation cohort study. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1154064
|
64 |
Ding-Zhong Peng, Jiong Lu, Bei Li, Hai-Jie Hu, Xi-Wen Ye, Xian-Ze Xiong, Nan-Sheng Cheng. A simple scoring system to predict early recurrence of Bismuth–Corlette type IV perihilar cholangiocarcinoma. Gastroenterology Report 2019; 7(5): 345 doi: 10.1093/gastro/goz012
|
65 |
Yueh-Wei Liu, Sin-Hua Moi, Wei-Feng Li, Chih-Che Lin, Chee-Chien Yong, Chih-Chi Wang, Yi-Hao Yen, Chih-Yun Lin. A preoperative model for predicting early recurrence in patients undergoing resection for single hepatocellular carcinoma. European Journal of Surgical Oncology 2023; 49(8): 1444 doi: 10.1016/j.ejso.2023.03.211
|
66 |
Shunsuke Onoe, Atsuyuki Maeda, Yuichi Takayama, Yasuyuki Fukami, Takamasa Takahashi, Masahito Uji, Yuji Kaneoka. The Prognostic Impact of the Lymphocyte-to-Monocyte Ratio in Resected Pancreatic Head Adenocarcinoma. Medical Principles and Practice 2019; 28(6): 517 doi: 10.1159/000501017
|
67 |
Ruoh-Yun Gau, Hsin-I Tsai, Ming-Chin Yu, Kun-Ming Chan, Wei-Chen Lee, Haw-En Wang, Sheng-Fu Wang, Mei-Ling Cheng, Chien-Chih Chiu, Hsin-Yi Chen, Chao-Wei Lee. Laparoscopic liver resection is associated with less significant muscle loss than the conventional open approach. World Journal of Surgical Oncology 2022; 20(1) doi: 10.1186/s12957-022-02854-1
|
68 |
永辉 马. Establishment and Validation of Nomogram for Predicting Early Postoperative Recurrence of Liver Cancer. Advances in Clinical Medicine 2024; 14(03): 1859 doi: 10.12677/acm.2024.143917
|
69 |
Fumitoshi Hirokawa, Michihiro Hayashi, Mitsuhiro Asakuma, Tetsunosuke Shimizu, Yoshihiro Inoue, Kazuhisa Uchiyama. Risk factors and patterns of early recurrence after curative hepatectomy for hepatocellular carcinoma. Surgical Oncology 2016; 25(1): 24 doi: 10.1016/j.suronc.2015.12.002
|
70 |
Vincent P. Groot, Lois A. Daamen, Jeroen Hagendoorn, Inne H.M. Borel Rinkes, Hjalmar C. van Santvoort, I. Quintus Molenaar. Use of imaging during symptomatic follow-up after resection of pancreatic ductal adenocarcinoma. Journal of Surgical Research 2018; 221: 152 doi: 10.1016/j.jss.2017.08.023
|
71 |
Andrew K.Y. Fung, Nicole M.Y. Cheng, Charing C.N. Chong, Kit-Fai Lee, John Wong, Sunny Y.S. Cheung, Hon-Ting Lok, Paul B.S. Lai, Kelvin K.C. Ng. Single-center experience on actual mid-term (≥5 years) and long-term (≥10 years) survival outcome in patients with hepatocellular carcinoma after curative hepatectomy. Medicine 2020; 99(48): e23358 doi: 10.1097/MD.0000000000023358
|
72 |
Yueh-Wei Liu, Chee-Chien Yong, Chih-Che Lin, Chih-Chi Wang, Chao-Long Chen, Yu-Fan Cheng, Jing-Houng Wang, Yi-Hao Yen. Six months as a cutoff time point to define early recurrence after liver resection of hepatocellular carcinoma based on post-recurrence survival. Updates in Surgery 2021; 73(2): 399 doi: 10.1007/s13304-020-00931-2
|
73 |
Yaowen Zhang, Junhui Gao, Anping Zheng, Haijun Yang, Jian Li, Shouxin Wu, Jiangman Zhao, Peng Meng, Fuyou Zhou. Definition and risk factors of early recurrence based on affecting prognosis of esophageal squamous cell carcinoma patients after radical resection. Translational Oncology 2021; 14(6): 101066 doi: 10.1016/j.tranon.2021.101066
|
74 |
Wang Yao, Miao Xue, Mingjian Lu, Yu Wang, Yue Zhao, Yanqin Wu, Wenzhe Fan, Jiaping Li. Diffuse Recurrence of Hepatocellular Carcinoma After Liver Resection: Transarterial Chemoembolization (TACE) Combined With Sorafenib Versus TACE Monotherapy. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.574668
|
75 |
Kai Zhang, Changcheng Tao, Tana Siqin, Jianxiong Wu, Weiqi Rong. Establishment, validation and evaluation of predictive model for early relapse after R0 resection in hepatocellular carcinoma patients with microvascular invasion. Journal of Translational Medicine 2021; 19(1) doi: 10.1186/s12967-021-02940-0
|
76 |
Leyao Wang, Xiaohong Ma, Bing Feng, Shuang Wang, Meng Liang, Dengfeng Li, Sicong Wang, Xinming Zhao. Multi-Sequence MR-Based Radiomics Signature for Predicting Early Recurrence in Solitary Hepatocellular Carcinoma ≤5 cm. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.899404
|
77 |
Ming-Da Wang, Li-Yang Sun, Guo-Jun Qian, Chao Li, Li-Hui Gu, Lan-Qing Yao, Yong-Kang Diao, Timothy M. Pawlik, Wan Yee Lau, Dong-Sheng Huang, Feng Shen, Tian Yang. Prothrombin induced by vitamin K Absence-II versus alpha-fetoprotein in detection of both resectable hepatocellular carcinoma and early recurrence after curative liver resection: A retrospective cohort study. International Journal of Surgery 2022; 105: 106843 doi: 10.1016/j.ijsu.2022.106843
|
78 |
Akihiro Tanemura, Daisuke Noguchi, Toru Shinkai, Takahiro Ito, Aoi Hayasaki, Kazuyuki Gyoten, Takehiro Fujii, Yusuke Iizawa, Yasuhiro Murata, Naohisa Kuriyama, Masashi Kishiwada, Shugo Mizuno. Prognostic significance of early and multiple recurrences after curative resection for hepatocellular carcinoma. BMC Surgery 2024; 24(1) doi: 10.1186/s12893-024-02642-6
|
79 |
Tsung-Jung Tsai, Kai-Jyun Syu, Xuan-Yuan Huang, Yu Shih Liu, Chang-Wei Chen, Yen-Hang Wu, Ching-Min Lin, Yu-Yao Chang. Identifying timing and risk factors for early recurrence of resectable rectal cancer: A single center retrospective study. World Journal of Gastrointestinal Surgery 2024; 16(9): 2842-2852 doi: 10.4240/wjgs.v16.i9.2842
Abstract(93) |
Core Tip(74) |
Full Article(HTML)(481)
|
Full Article with Cover (PDF)-5627K(11)
|
Audio-1669K(2)
|
Peer-Review Report-231K(11)
|
Answering Reviewers-88K(12)
|
Supplementary Material-93K(9)
|
Full Article (PDF)-5277K(17)
|
Full Article (XML)-106K(10)
|
Times Cited (0)
|
Total Visits (1168)
|
Open
|
80 |
Chao‑Wei Lee, Sey‑En Lin, Hsin‑I Tsai, Po‑Jung Su, Chia‑Hsun Hsieh, Yung‑Chia Kuo, Chang‑Mu Sung, Cheng‑Yu Lin, Chi‑Neu Tsai, Ming‑Chin Yu. Cadherin 17 is related to recurrence and poor prognosis of cytokeratin 19‑positive hepatocellular carcinoma. Oncology Letters 2017; doi: 10.3892/ol.2017.7320
|